This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard G. Fadal, MD; Donald J. Nalebuff, MD

Arch Otolaryngol. 1980;106(1):38-43.

Abstract
• Forty-six patients with allergic rhinitis who were refractory to antihistamine/decongestant drugs were entered into a study to evaluate the effectiveness of optimal dose immunotherapy. Of the patients described, 91% reported symptomatic improvement within 24 weeks. Total IgE was seen to decrease in 76% of the patients in the same time frame. Nasal eosinophilia and specific IgE antibodies also were seen to decrease substantially. The results of this study indicate that immunotherapy, based on the patient's sensitivity as measured by specific serum antibody titers and titrated skin end points, is effective in alleviating symptoms and altering abnormal immunological factors.

(Arch Otolaryngol 106:38-43, 1980)

Author Affiliations
From the Division of Otorhinolaryngology, University of Alabama in Birmingham (Dr Fadal), and the Department of Otolaryngology, Holy Name Hospital, Teaneck, NJ (Dr Nalebuff).

Footnotes
Accepted for publication Nov 20, 1978.

Reprint requests to PO Box 3327, Waco, TX 76707 (Dr Fadal).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?